Science submits BCI for vision restoration for CE mark

Brain-computer interface (BCI) developer Science Corporation today said it submitted its Prima retinal implant for CE mark approval.

Neuralink co-founder Max Hodak founded Science, which unveiled its Science Eye BCI platform in 2022. The Science Eye is a visual prosthesis that targets retinitis pigmentosa (RP) and dry age-related macular degeneration (AMD), two forms of serious blindness. Science featured on MassDevice‘s list of BCI companies you need to know in 2024.

Prima retinal implant technology — developed by Pixium Vision as well — is a photovoltaic substitute of photoreceptors. The technology has FDA breakthrough device designation. It provides simultaneous use of the central prosthetic and peripheral natural vision. The company reported positive clinical data for the platform last year.

Sign up for Blog Updates